| __timestamp | Corcept Therapeutics Incorporated | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 2917513 |
| Thursday, January 1, 2015 | 36949000 | 7878291 |
| Friday, January 1, 2016 | 45240000 | 8366794 |
| Sunday, January 1, 2017 | 62416000 | 6610381 |
| Monday, January 1, 2018 | 81289000 | 6556000 |
| Tuesday, January 1, 2019 | 100359000 | 6930000 |
| Wednesday, January 1, 2020 | 105326000 | 8758000 |
| Friday, January 1, 2021 | 122356000 | 10806000 |
| Saturday, January 1, 2022 | 152848000 | 9844000 |
| Sunday, January 1, 2023 | 184259000 | 13481000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Corcept Therapeutics Incorporated and Soleno Therapeutics, Inc. over the past decade.
Corcept Therapeutics has demonstrated a robust increase in SG&A expenses, growing from approximately $35 million in 2014 to $184 million in 2023. This nearly 426% increase reflects the company's strategic investments in expanding its operations and market reach.
In contrast, Soleno Therapeutics has maintained a more conservative growth in SG&A expenses, rising from around $2.9 million in 2014 to $13.5 million in 2023, marking a 363% increase. This steady approach highlights Soleno's focus on sustainable growth and cost management.
Both companies showcase distinct strategies in managing their operational costs, offering valuable insights into their business models.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared